Journal of Personalized Medicine Review Genetic Counselling Improves the Molecular Characterisation of Dementing Disorders Stefania Zampatti 1, Michele Ragazzo 2, Cristina Peconi 1, Serena Luciano 1, Stefano Gambardella 3,4, Valerio Caputo 2 , Claudia Strafella 1 , Raffaella Cascella 1,5, Carlo Caltagirone 6 and Emiliano Giardina 1,2,* 1 Genomic Medicine Laboratory UILDM, IRCCS Fondazione Santa Lucia, 00179 Rome, Italy;
[email protected] (S.Z.);
[email protected] (C.P.);
[email protected] (S.L.);
[email protected] (C.S.);
[email protected] (R.C.) 2 Department of Biomedicine and Prevention, Tor Vergata University of Rome, 00133 Rome, Italy;
[email protected] (M.R.);
[email protected] (V.C.) 3 IRCCS Neuromed, 86077 Pozzilli, Italy;
[email protected] 4 Department of Biomolecular Sciences, University of Urbino “Carlo Bo”, 61029 Urbino, Italy 5 Department of Biomedical Sciences, Catholic University Our Lady of Good Counsel, 1000 Tirana, Albania 6 Department of Clinical and Behavioral Neurology, IRCCS Fondazione Santa Lucia, 00179 Rome, Italy;
[email protected] * Correspondence:
[email protected] Abstract: Dementing disorders are a complex group of neurodegenerative diseases characterised by different, but often overlapping, pathological pathways. Genetics have been largely associated with the development or the risk to develop dementing diseases. Recent advances in molecular technologies permit analyzing of several genes in a small time, but the interpretation analysis is Citation: Zampatti, S.; Ragazzo, M.; complicated by several factors: the clinical complexity of neurodegenerative disorders, the frequency Peconi, C.; Luciano, S.; Gambardella, of co-morbidities, and the high phenotypic heterogeneity of genetic diseases.